This report contains market size and forecasts of Nuclear Medicine/Radiopharmaceutic in global, including the following market information:
Global Nuclear Medicine/Radiopharmaceutic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nuclear Medicine/Radiopharmaceutic Market Sales, 2016-2021, 2022-2027, (Kiloton)
Global top five Nuclear Medicine/Radiopharmaceutic companies in 2020 (%)
The global Nuclear Medicine/Radiopharmaceutic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine/Radiopharmaceutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine/Radiopharmaceutic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Type, 2020 (%)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Global Nuclear Medicine/Radiopharmaceutic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Application, 2020 (%)
Diagnostic
Therapeutic
Global Nuclear Medicine/Radiopharmaceutic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine/Radiopharmaceutic revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nuclear Medicine/Radiopharmaceutic revenues share in global market, 2020 (%)
Key companies Nuclear Medicine/Radiopharmaceutic sales in global market, 2016-2021 (Estimated), (Kiloton)
Key companies Nuclear Medicine/Radiopharmaceutic sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine/Radiopharmaceutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine/Radiopharmaceutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine/Radiopharmaceutic Overall Market Size
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2027
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nuclear Medicine/Radiopharmaceutic Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Nuclear Medicine/Radiopharmaceutic Players in Global Market
3.2 Top Global Nuclear Medicine/Radiopharmaceutic Companies Ranked by Revenue
3.3 Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies
3.4 Global Nuclear Medicine/Radiopharmaceutic Sales by Companies
3.5 Global Nuclear Medicine/Radiopharmaceutic Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nuclear Medicine/Radiopharmaceutic Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Market Size Markets, 2021 & 2027
4.1.2 Tc-99
4.1.3 I-123/131
4.1.4 In-111
4.1.5 Xe-133
4.1.6 Th-201
4.1.7 Ga-67
4.1.8 Other
4.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
4.2.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
4.2.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
4.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
4.3.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
4.3.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
4.4 By Type - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2027
5.1.2 Diagnostic
5.1.3 Therapeutic
5.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
5.2.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
5.2.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
5.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
5.3.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
5.3.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
5.4 By Application - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2027
6.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
6.2.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
6.2.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
6.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
6.3.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
6.3.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027
6.4.2 By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, 2016-2027
6.4.3 US Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.4.4 Canada Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.4.5 Mexico Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027
6.5.2 By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, 2016-2027
6.5.3 Germany Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.4 France Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.5 U.K. Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.6 Italy Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.7 Russia Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.8 Nordic Countries Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.5.9 Benelux Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027
6.6.2 By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, 2016-2027
6.6.3 China Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.6.4 Japan Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.6.5 South Korea Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.6.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.6.7 India Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027
6.7.2 By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, 2016-2027
6.7.3 Brazil Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.7.4 Argentina Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, 2016-2027
6.8.3 Turkey Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.8.4 Israel Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.8.5 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
6.8.6 UAE Nuclear Medicine/Radiopharmaceutic Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Corporate Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.1.5 GE Healthcare Key News
7.2 Bracco Imaging
7.2.1 Bracco Imaging Corporate Summary
7.2.2 Bracco Imaging Business Overview
7.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.2.5 Bracco Imaging Key News
7.3 Mallinckrodt
7.3.1 Mallinckrodt Corporate Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.3.5 Mallinckrodt Key News
7.4 Lantheus Medical Imaging
7.4.1 Lantheus Medical Imaging Corporate Summary
7.4.2 Lantheus Medical Imaging Business Overview
7.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.4.5 Lantheus Medical Imaging Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.5.5 Bayer Key News
7.6 Jubilant Pharma
7.6.1 Jubilant Pharma Corporate Summary
7.6.2 Jubilant Pharma Business Overview
7.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.6.5 Jubilant Pharma Key News
7.7 Nordion
7.7.1 Nordion Corporate Summary
7.7.2 Nordion Business Overview
7.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.4.4 Nordion Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.7.5 Nordion Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 SIEMENS
7.9.1 SIEMENS Corporate Summary
7.9.2 SIEMENS Business Overview
7.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.9.5 SIEMENS Key News
7.10 China Isotope & Radiation
7.10.1 China Isotope & Radiation Corporate Summary
7.10.2 China Isotope & Radiation Business Overview
7.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.10.5 China Isotope & Radiation Key News
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Corporate Summary
7.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Business Overview
7.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2016-2021)
7.11.5 Yantai Dongcheng Biochemicals Key News
8 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, Analysis
8.1 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, 2016-2027
8.2 Nuclear Medicine/Radiopharmaceutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine/Radiopharmaceutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis
10.1 Nuclear Medicine/Radiopharmaceutic Industry Value Chain
10.2 Nuclear Medicine/Radiopharmaceutic Upstream Market
10.3 Nuclear Medicine/Radiopharmaceutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Nuclear Medicine/Radiopharmaceutic in Global Market
Table 2. Top Nuclear Medicine/Radiopharmaceutic Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Companies, 2016-2021
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales by Companies, (Kiloton), 2016-2021
Table 6. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2021) & (US$/Ton)
Table 8. Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 9. List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals